在剖腹产妇女中,手术期间使用石膏药和产后抑郁症:一项随机临床试验
Li Ren1, Ting Zhang1, Bingyu Zou1
1Department of Anesthesiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
JAMA network open
|February 13, 2025
概括
在剖腹产分娩的妇女中,手术期间使用的石胺显著降低了产后抑郁症 (PPD). 这项研究突出了埃斯基坦胺的作用.
科学领域:
- 产科和妇科 产科和妇科
- 麻醉学 麻醉学
- 精神病学是一个精神病学.
背景情况:
- 产后抑郁症 (PPD) 在分娩后影响了许多妇女.
- 在临床试验中,Esketamine在减少PPD方面表现有前途.
- 关于埃斯基他胺用于PPD预防的现实世界临床数据有限.
研究的目的:
- 评估手术期间使用的埃斯基坦胺在接受剖腹产的妇女中预防PPD的临床有效性.
- 在现实临床环境中评估埃斯基坦胺对PPD发病率的影响.
主要方法:
- 一项随机临床试验,涉及308名接受剖腹产的妇女.
- 参与者被随机分配1:1接受胺注入或盐水控制.
- 产后抑郁症在6周后使用爱丁堡产后抑郁症量表进行评估.
主要成果:
- 在产后6周后,PPD的发病率在乙胺组 (10.4%) 与对照组 (19.5%) 相比显著较低.
- 对于PPD的相对风险为0.53 (95% CI,0.30-0.93;P=.02) 与埃斯基坦胺.
- 该研究包括2023年3月至2024年2月在中国一家三级医院的患者.
结论:
- 在剖腹产分娩后进行的手术内施用石胺是有效的降低PPD的发生率.
- 在这项临床试验中,石胺在预防PPD方面具有显著的优势.
- 需要进行进一步的研究,以探索在临床实践中对PPD预防esketamine的疗效和安全性.
更多相关视频
09:07Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins
Published on: August 15, 2017
12.0K
06:58Non-restraining EEG Radiotelemetry: Epidural and Deep Intracerebral Stereotaxic EEG Electrode Placement
Published on: June 25, 2016
19.0K
相关概念视频
Local Anesthetics: Clinical Application as Epidural Anesthesia
408
Epidural anesthetics are administered in the fat-filled epidural space, the outermost part of the spinal canal. This technique is commonly employed for pain management and anesthesia during lower abdomen and pelvis surgeries or labor and delivery.
Since epidural anesthetics can be infused through an epidural catheter, all types of drugs, including short-acting ones, can be administered. Chloroprocaine and lidocaine are examples of short and long-duration anesthetics, respectively. Bupivacaine...
Since epidural anesthetics can be infused through an epidural catheter, all types of drugs, including short-acting ones, can be administered. Chloroprocaine and lidocaine are examples of short and long-duration anesthetics, respectively. Bupivacaine...
408
Electroconvulsive Therapy
22
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
22
